Dr. Reddy's Laboratories Limited

NYSE:RDY Stock Report

Market Cap: US$13.3b

Dr. Reddy's Laboratories Management

Management criteria checks 4/4

Dr. Reddy's Laboratories' CEO is Erez Israeli, appointed in Apr 2018, has a tenure of 6.75 years. directly owns 0.007% of the company’s shares, worth $871.25K. The average tenure of the management team and the board of directors is 6.8 years and 3 years respectively.

Key information

Erez Israeli

Chief executive officer

₹197.1m

Total compensation

CEO salary percentagen/a
CEO tenure6.8yrs
CEO ownership0.007%
Management average tenure6.8yrs
Board average tenure3yrs

Recent management updates

Recent updates

Dr. Reddy's Laboratories: Economic Factors Square Off To Reiterate Buy

Aug 13

Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements

Nov 29

Dr. Reddy's: Continued Q2 Earnings Growth, Supports Long-Term Investment Outlook

Oct 27

Dr. Reddy's: Growth Supported By New Labels, Profitability

Aug 23

Dr. Reddy's Laboratories: Unpacking The Critical Factors, Reiterate Buy

Jun 07

Dr. Reddy's Laboratories: Positive Q3 Results, Growth Supportive Of Buy

Feb 16

Dr. Reddy's prepare to file for Rituxan biosimilar in US, EU as trials completed

Jan 20

Dr. Reddy's Needs Time For Generics Sales To Replace Sputnik Revenue

Nov 07

Dr. Reddy's GAAP EPS of $0.90, revenue of $660M misses by $12.78M

Jul 28

Dr. Reddy's launches generic drugs for allergies in US

Jul 22

Dr. Reddy's, EQRx team up to develop drugs for cancer, immune-inflammatory diseases

Jul 05

CEO Compensation Analysis

How has Erez Israeli's remuneration changed compared to Dr. Reddy's Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹53b

Jun 30 2024n/an/a

₹56b

Mar 31 2024₹197mn/a

₹56b

Dec 31 2023n/an/a

₹52b

Sep 30 2023n/an/a

₹51b

Jun 30 2023n/an/a

₹47b

Mar 31 2023₹195mn/a

₹45b

Dec 31 2022n/an/a

₹36b

Sep 30 2022n/an/a

₹31b

Jun 30 2022n/an/a

₹30b

Mar 31 2022₹127mn/a

₹24b

Dec 31 2021n/an/a

₹26b

Sep 30 2021n/an/a

₹19b

Jun 30 2021n/an/a

₹17b

Mar 31 2021₹120mn/a

₹17b

Dec 31 2020n/an/a

₹21b

Sep 30 2020n/an/a

₹15b

Jun 30 2020n/an/a

₹19b

Mar 31 2020₹195m₹107m

₹19b

Dec 31 2019n/an/a

₹16b

Sep 30 2019n/an/a

₹27b

Jun 30 2019n/an/a

₹21b

Mar 31 2019₹123mn/a

₹19b

Compensation vs Market: Erez's total compensation ($USD2.29M) is below average for companies of similar size in the US market ($USD12.79M).

Compensation vs Earnings: Erez's compensation has been consistent with company performance over the past year.

CEO

Erez Israeli (56 yo)

6.8yrs

Tenure

₹197,090,000

Compensation

Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019 and has been its Member of the Management Council since April 02, 2018. Mr. Israeli served as...

Leadership Team

NamePositionTenureCompensationOwnership
Gunupati Prasad
Co-Chairman38.8yrs₹186.28m13.07%
$ 1.7b
Kallam Reddy
Chairman of the Board & Member of the Management Council32yrs₹116.17m13.61%
$ 1.8b
Erez Israeli
CEO & Member of the Management Council6.8yrs₹197.09m0.0066%
$ 871.3k
Mannam Venkatanarasimham
CFO & Member of the Management Councilless than a year₹48.82m0.0057%
$ 754.2k
Krishna Venkatesh
Global Head of Quality and Pharmacovigilance & Member of the Management Councilless than a year₹6.15mno data
Deepak Sapra
CEO of API & Services & Member of Management Councilno data₹41.90m0.0027%
$ 356.5k
Venkata Motupalli
CEO of Branded Markets - India & Emerging Countries and Member of Management Councilno data₹82.74m0.016%
$ 2.1m
Archana Bhaskar
EVP, Head of Corporate Communications7.6yrs₹65.21m0.0063%
$ 844.6k
Sanjay Sharma
Executive VP7.4yrs₹66.05mno data
Patrick Aghanian
CEO of European Generics & Member of Management Councilno data₹63.09mno data
Sushrut Kulkarni
Global Head of Integrated Product Development Organisation & Member of the Management Councilno data₹55.63m0.000020%
$ 2.7k
Jayanth Sridhar
Global Head – Biologics & Member of the Management Councilno data₹34.59mno data

6.8yrs

Average Tenure

56yo

Average Age

Experienced Management: RDY's management team is seasoned and experienced (6.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gunupati Prasad
Co-Chairman38.8yrs₹186.28m13.07%
$ 1.7b
Kallam Reddy
Chairman of the Board & Member of the Management Council32yrs₹116.17m13.61%
$ 1.8b
R. Rajgopalan
Member of the Scientific Advisory Boardno data₹8.36mno data
Arun Kumar
Independent Director2.4yrs₹18.77mno data
Shikha Sharma
Independent Director6yrs₹13.34mno data
K. Reddy
Member of the Scientific Advisory Boardno datano datano data
Leo Puri
Lead Independent Director6.3yrs₹17.10mno data
Kodumudi Krishnan
Independent Director3yrs₹14.18mno data
Sanjiv Mehta
Independent Director1.1yrs₹3.32mno data
Alpna Seth
Independent Director2yrs₹8.25mno data
Penny Wan
Independent Director3yrs₹17.10mno data
Claudio Albrecht
Independent Director1.7yrs₹16.09mno data

3.0yrs

Average Tenure

64yo

Average Age

Experienced Board: RDY's board of directors are considered experienced (3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 04:58
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Reddy's Laboratories Limited is covered by 81 analysts. 36 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Prashant NairAmbit Capital
null nullAnand Rathi Shares and Stock Brokers Limited